MXPA03001422A - Pirazoles substituidos. - Google Patents

Pirazoles substituidos.

Info

Publication number: MXPA03001422A
Authority: MX; Mexico
Prior art keywords: substituted pyrazoles; methods; pyrazoles; substituted; cathepsin
Prior art date: 2000-08-14

Application number

MXPA03001422A

Other languages

English (en)

Inventor

James P Edwards

Original Assignee

Johnson & Johnson

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-14

Filing date

2001-08-10

Publication date

2004-01-26

2001-08-10 Application filed by Johnson & Johnson filed Critical Johnson & Johnson

2004-01-26 Publication of MXPA03001422A publication Critical patent/MXPA03001422A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

MXPA03001422A 2000-08-14 2001-08-10 Pirazoles substituidos. MXPA03001422A (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US22517800P	2000-08-14	2000-08-14
US09/927,324 US6953793B2 (en)	2000-08-14	2001-08-10	Substituted pyrazoles
PCT/US2001/025290 WO2002014315A2 (en)	2000-08-14	2001-08-10	Substituted pyrazoles

Publications (1)

Publication Number	Publication Date
MXPA03001422A true MXPA03001422A (es)	2004-01-26

Family

ID=26919364

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03001422A MXPA03001422A (es)	2000-08-14	2001-08-10	Pirazoles substituidos.

Country Status (19)

Country	Link
US (2)	US6953793B2 (es)
EP (1)	EP1309593B1 (es)
JP (1)	JP5049447B2 (es)
KR (1)	KR100837193B1 (es)
AT (1)	ATE320427T1 (es)
AU (2)	AU8645401A (es)
BR (1)	BRPI0113286B8 (es)
CA (1)	CA2419552C (es)
CZ (1)	CZ307185B6 (es)
DE (1)	DE60118004T2 (es)
DK (1)	DK1309593T3 (es)
ES (1)	ES2261463T3 (es)
HU (1)	HU230538B1 (es)
MX (1)	MXPA03001422A (es)
NZ (1)	NZ524191A (es)
PL (1)	PL213103B1 (es)
PT (1)	PT1309593E (es)
RU (1)	RU2317988C2 (es)
WO (1)	WO2002014315A2 (es)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6566372B1 (en)	1999-08-27	2003-05-20	Ligand Pharmaceuticals Incorporated	Bicyclic androgen and progesterone receptor modulator compounds and methods
PL213103B1 (pl) *	2000-08-14	2013-01-31	Ortho Mcneil Pharm Inc	Podstawiona pochodna pirazolu, jej zastosowanie i zawierajaca ja kompozycja farmaceutyczna
EP1309591B1 (en) *	2000-08-14	2007-01-24	Ortho-McNeil Pharmaceutical, Inc.	Substituted pyrazoles
US20050101587A9 (en) *	2000-08-14	2005-05-12	Butler Christopher R.	Method for treating allergies using substituted pyrazoles
US7064123B1 (en) *	2000-12-22	2006-06-20	Aventis Pharmaceuticals Inc.	Compounds and compositions as cathepsin inhibitors
CZ20032850A3 (cs) *	2001-04-18	2004-02-18	Euro-Celtique, S. A.	Analogy nociceptinu
JP4380992B2 (ja) *	2001-04-18	2009-12-09	ユーロ−セルティークエス．エイ．	ノシセプチン類似体
US20040147503A1 (en) *	2002-06-04	2004-07-29	Sheila Zipfeil	Novel compounds and compositions as cathepsin inhibitors
TWI335311B (en)	2002-09-24	2011-01-01	Novartis Ag	Organic compounds
US7109243B2 (en)	2003-03-24	2006-09-19	Irm Llc	Inhibitors of cathepsin S
US7384970B2 (en)	2003-03-24	2008-06-10	Irm Llc	Inhibitors of cathepsin S
US7173051B2 (en)	2003-06-13	2007-02-06	Irm, Llc	Inhibitors of cathepsin S
US7256207B2 (en)	2003-08-20	2007-08-14	Irm Llc	Inhibitors of cathepsin S
FR2885904B1 (fr) *	2005-05-19	2007-07-06	Aventis Pharma Sa	Nouveaux derives du fluorene, compositions les contenant et utilisation
SI1906965T1 (sl) *	2005-06-22	2015-09-30	Chemocentryx, Inc.	Azaindolne spojine in postopki uporabe
TW200813018A (en)	2006-06-09	2008-03-16	Astrazeneca Ab	Novel compounds
CL2007003590A1 (es) *	2006-12-12	2008-02-29	Wyeth Corp	Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transt
US20090099157A1 (en) *	2007-02-15	2009-04-16	Ameriks Michael K	Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s
US20080207683A1 (en) *	2007-02-15	2008-08-28	Darin Allen	Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20080200454A1 (en) *	2007-02-15	2008-08-21	Ameriks Michael K	Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20090118274A1 (en) *	2007-02-15	2009-05-07	Darin Allen	Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20080269241A1 (en) *	2007-02-15	2008-10-30	Darin Allen	Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US8119661B2 (en)	2007-09-11	2012-02-21	Astrazeneca Ab	Piperidine derivatives and their use as muscarinic receptor modulators
SG10201406263SA (en)	2008-06-20	2015-02-27	Novartis Ag	Paediatric compositions for treating multiple sclerosis
US9643922B2 (en)	2008-08-18	2017-05-09	Yale University	MIF modulators
US9540322B2 (en)	2008-08-18	2017-01-10	Yale University	MIF modulators
BRPI0917394A2 (pt) *	2008-08-18	2019-09-24	Univ Yale	moduladores de mif
TWI475020B (zh) *	2009-03-12	2015-03-01		The substituted nicotine amide as a KCNQ2 / 3 modifier
CN102574850A (zh)	2009-08-12	2012-07-11	詹森药业有限公司	用于制备组织蛋白酶s抑制剂的方法
WO2012088266A2 (en)	2010-12-22	2012-06-28	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
ES2984771T3 (es)	2012-06-13	2024-10-31	Incyte Holdings Corp	Compuestos tricíclicos sustituidos como inhibidores de FGFR
WO2014026125A1 (en)	2012-08-10	2014-02-13	Incyte Corporation	Pyrazine derivatives as fgfr inhibitors
CA2890018A1 (en)	2012-11-05	2014-05-08	Nant Holdings Ip, Llc	Substituted indol-5-ol derivatives and their therapeutical applications
ES2625945T3 (es)	2012-11-14	2017-07-21	Glaxosmithkline Llc	Tieno[3,2-c]piridin-4(5H)-onas como inhibidores de bet
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
BR112015022307A2 (pt)	2013-03-15	2017-07-18	Nantbioscience Inc	derivados substituídos indol-5-ol e as suas aplicações terapêuticas
EA035095B1 (ru)	2013-04-19	2020-04-27	Инсайт Холдингс Корпорейшн	Бициклические гетероциклы в качестве ингибиторов fgfr
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
WO2016087352A1 (en) *	2014-12-02	2016-06-09	F. Hoffmann-La Roche Ag	Novel piperidine derivatives
US9580423B2 (en)	2015-02-20	2017-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
EA038045B1 (ru)	2015-02-20	2021-06-28	Инсайт Корпорейшн	Бициклические гетероциклы в качестве ингибиторов fgfr
EP3319968A1 (en)	2015-07-06	2018-05-16	Rodin Therapeutics, Inc.	Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
PT3319959T (pt)	2015-07-06	2021-12-06	Alkermes Inc	Inibidores hetero-halo de histona desacetilase
CA3049443A1 (en)	2017-01-11	2018-07-19	Rodin Therapeutics, Inc.	Bicyclic inhibitors of histone deacetylase
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
JP7152471B2 (ja)	2017-08-07	2022-10-12	ロダン・セラピューティクス，インコーポレーテッド	ヒストン脱アセチル化酵素の二環阻害剤
EP3694322B1 (en)	2017-10-09	2024-07-03	Terumo BCT Biotechnologies, LLC	Lyophilization container and method of using same
US11174257B2 (en)	2018-05-04	2021-11-16	Incyte Corporation	Salts of an FGFR inhibitor
RS66310B1 (sr)	2018-05-04	2025-01-31	Incyte Corp	Čvrsti oblici inhibitora fgfr i procesi za njegovu pripremu
WO2020185532A1 (en)	2019-03-08	2020-09-17	Incyte Corporation	Methods of treating cancer with an fgfr inhibitor
EP3938741B1 (en)	2019-03-14	2024-05-01	Terumo BCT Biotechnologies, LLC	Lyophilization container fill fixture, system and method of use
WO2021007269A1 (en)	2019-07-09	2021-01-14	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en)	2019-10-01	2021-04-08	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
PH12022550892A1 (en)	2019-10-14	2023-05-03	Incyte Corp	Bicyclic heterocycles as fgfr inhibitors
US11566028B2 (en)	2019-10-16	2023-01-31	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
AU2020395185A1 (en)	2019-12-04	2022-06-02	Incyte Corporation	Derivatives of an FGFR inhibitor
EP4069696A1 (en)	2019-12-04	2022-10-12	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
US12012409B2 (en)	2020-01-15	2024-06-18	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
JP2024513575A (ja)	2021-04-12	2024-03-26	インサイト・コーポレイション	Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法
WO2022261160A1 (en)	2021-06-09	2022-12-15	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
TW202313610A (zh)	2021-06-09	2023-04-01	美商英塞特公司	作為ｆｇｆｒ抑制劑之三環雜環

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US856514A (en) *	1907-03-15	1907-06-11	William T Adams	Cheese-cutter.
US3743409A (en)	1971-06-11	1973-07-03	Xerox Corp	Cutter assembly
JPS5090172A (es)	1973-12-13	1975-07-19
US3994890A (en)	1974-01-31	1976-11-30	Chugai Seiyaku Kabushiki Kaisha	1-Aminoalkyl, 3-phenyl indazoles
JPS5640714B2 (es) *	1974-03-04	1981-09-22
DK27383A (da)	1982-02-17	1983-08-18	Lepetit Spa	Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner
JPH0615542B2 (ja) *	1986-07-22	1994-03-02	吉富製薬株式会社	ピラゾロピリジン化合物
FR2642759B1 (fr)	1989-02-09	1991-05-17	Laboratorios Esteve Sa	Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2673628B1 (fr)	1991-03-07	1993-07-09	Esteve Labor Dr	Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
US5264576A (en)	1992-10-22	1993-11-23	Hoechst-Roussel Pharmaceuticals Incorporated	Pyrazolo[4,3-c]pyridines which are intermediates
FR2705962B1 (fr) *	1993-06-03	1995-07-13	Rhone Poulenc Agrochimie	Arylpyrazoles fongicides.
EP0707585A1 (en) *	1993-07-06	1996-04-24	Pfizer Inc.	Bicyclic tetrahydro pyrazolopyridines
FR2712808B1 (fr)	1993-11-25	1996-02-16	Esteve Labor Dr	Utilisation des dérivés de 1-{4-[4-aryl(ou hétéroaryl)-1-pipérazinyl]-butyl}-1-H-azole pour la préparation de médicaments destinés au traitement des troubles de la sécrétion gastrique .
IL112759A0 (en)	1994-02-25	1995-05-26	Khepri Pharmaceuticals Inc	Novel cysteine protease inhibitors
PL322409A1 (en)	1995-03-24	1998-01-19	Arris Pharm Corp	Reversible protease inhibitors
US5776718A (en)	1995-03-24	1998-07-07	Arris Pharmaceutical Corporation	Reversible protease inhibitors
TW438591B (en)	1995-06-07	2001-06-07	Arris Pharm Corp	Reversible cysteine protease inhibitors
FR2742052B1 (fr)	1995-12-12	1998-04-10	Esteve Labor Dr	Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports
PT912601E (pt)	1996-04-22	2004-04-30	Massachusetts Inst Technology	Supressao da resposta imune via inibicao da catepsina s
WO1998056785A1 (en)	1997-06-12	1998-12-17	Sumitomo Pharmaceuticals Co., Ltd.	Pyrazole derivatives
BR9813197A (pt)	1997-11-05	2000-08-29	Novartis Ag	Dipeptìdeo nitrilas
GB9806287D0 (en)	1998-03-24	1998-05-20	Synphar Lab Inc	Monobactam enzyme inhibitors
WO1999058153A1 (en)	1998-05-08	1999-11-18	Brigham & Women's Hospital	Methods of diagnosing and modulating autoimmunity
AU2560000A (en)	1999-02-20	2000-09-04	Astrazeneca Ab	Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin
EP1159273A1 (en)	1999-03-02	2001-12-05	Boehringer Ingelheim Pharmaceuticals Inc.	Compounds useful as reversible inhibitors of cathepsin s
TW200404789A (en)	1999-03-15	2004-04-01	Axys Pharm Inc	Novel compounds and compositions as protease inhibitors
CA2379747C (en)	1999-07-30	2008-09-23	Boehringer Ingelheim Pharmaceuticals, Inc.	Novel succinate derivative compounds useful as cysteine protease inhibitors
WO2001019796A1 (en)	1999-09-16	2001-03-22	Axys Pharmaceuticals, Inc.	Compounds and pharmaceutical compositions as cathepsin s inhibitors
KR20020062312A (ko)	1999-12-03	2002-07-25	오노 야꾸힝 고교 가부시키가이샤	１,３,４-옥사디아졸린 유도체 및 이들을 유효 성분으로하는 약제
PL213103B1 (pl) *	2000-08-14	2013-01-31	Ortho Mcneil Pharm Inc	Podstawiona pochodna pirazolu, jej zastosowanie i zawierajaca ja kompozycja farmaceutyczna

2001
- 2001-08-10 PL PL360696A patent/PL213103B1/pl unknown
- 2001-08-10 DK DK01965898T patent/DK1309593T3/da active
- 2001-08-10 BR BRPI0113286A patent/BRPI0113286B8/pt not_active IP Right Cessation
- 2001-08-10 WO PCT/US2001/025290 patent/WO2002014315A2/en not_active Ceased
- 2001-08-10 MX MXPA03001422A patent/MXPA03001422A/es active IP Right Grant
- 2001-08-10 NZ NZ524191A patent/NZ524191A/en not_active IP Right Cessation
- 2001-08-10 RU RU2003107016/04A patent/RU2317988C2/ru not_active Application Discontinuation
- 2001-08-10 AU AU8645401A patent/AU8645401A/xx active Pending
- 2001-08-10 CA CA2419552A patent/CA2419552C/en not_active Expired - Lifetime
- 2001-08-10 ES ES01965898T patent/ES2261463T3/es not_active Expired - Lifetime
- 2001-08-10 AT AT01965898T patent/ATE320427T1/de active
- 2001-08-10 PT PT01965898T patent/PT1309593E/pt unknown
- 2001-08-10 JP JP2002519455A patent/JP5049447B2/ja not_active Expired - Lifetime
- 2001-08-10 US US09/927,324 patent/US6953793B2/en not_active Expired - Lifetime
- 2001-08-10 AU AU2001286454A patent/AU2001286454B2/en not_active Expired
- 2001-08-10 KR KR1020037002163A patent/KR100837193B1/ko not_active Expired - Lifetime
- 2001-08-10 DE DE60118004T patent/DE60118004T2/de not_active Expired - Lifetime
- 2001-08-10 HU HU0303108A patent/HU230538B1/hu not_active IP Right Cessation
- 2001-08-10 CZ CZ2003-429A patent/CZ307185B6/cs not_active IP Right Cessation
- 2001-08-10 EP EP01965898A patent/EP1309593B1/en not_active Expired - Lifetime
2005
- 2005-06-30 US US11/174,077 patent/US20050245576A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NZ524191A (en)	2004-11-26
BR0113286B1 (pt)	2013-04-16
RU2317988C2 (ru)	2008-02-27
ATE320427T1 (de)	2006-04-15
US20050245576A1 (en)	2005-11-03
DE60118004D1 (de)	2006-05-11
RU2003107016A (ru)	2004-11-27
BR0113286A (pt)	2003-09-09
KR100837193B1 (ko)	2008-06-13
BRPI0113286B8 (pt)	2021-05-25
HK1055422A1 (en)	2004-01-09
PL213103B1 (pl)	2013-01-31
US20030078419A1 (en)	2003-04-24
ES2261463T3 (es)	2006-11-16
DE60118004T2 (de)	2006-11-16
CZ307185B6 (cs)	2018-03-07
JP2004511440A (ja)	2004-04-15
CA2419552C (en)	2010-10-12
AU8645401A (en)	2002-02-25
KR20030060876A (ko)	2003-07-16
PL360696A1 (en)	2004-09-20
US6953793B2 (en)	2005-10-11
PT1309593E (pt)	2006-08-31
CA2419552A1 (en)	2002-02-21
AU2001286454B2 (en)	2006-09-14
HU230538B1 (hu)	2016-11-28
EP1309593B1 (en)	2006-03-15
CZ2003429A3 (cs)	2003-12-17
HUP0303108A3 (en)	2012-10-29
WO2002014315A2 (en)	2002-02-21
EP1309593A2 (en)	2003-05-14
WO2002014315A3 (en)	2002-06-13
JP5049447B2 (ja)	2012-10-17
DK1309593T3 (da)	2006-07-17
HUP0303108A2 (hu)	2004-01-28

Publication	Publication Date	Title
AU8645401A (en)	2002-02-25	Substituted pyrazoles
WO2002014314A3 (en)	2002-06-06	Substituted pyrazoles
WO2002014317A3 (en)	2002-07-04	Substituted pyrazoles
PL365683A1 (en)	2005-01-10	Selected fused pyrrolocarbazoles
IL153406A0 (en)	2003-07-06	Cyclopentanoindoles, compositions containing such compounds and methods of treatment
MXPA02011288A (es)	2004-09-10	Tioacetamidas substituidas.
AU2000233235A1 (en)	2001-09-17	Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
MXPA04003796A (es)	2004-07-30	Tioacetamidas sustituidas.
MY158159A (en)	2016-09-15	Novel fused pyrrolocarbazoles
SG149042A1 (en)	2009-01-29	Novel fused pyrrolocarbazoles
MXPA03005601A (es)	2004-12-02	Nuevos compuestos y composiciones como inhibidores de catepsina.
IL160171A0 (en)	2004-07-25	Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
GB0216001D0 (en)	2002-08-21	Process and composition
WO2004064737A3 (en)	2005-12-15	Therapeutics compositions
MXPA03010766A (es)	2005-03-07	Nuevos compuestos y composiciones como inhibicores de las catepsinas.
MXPA03010737A (es)	2004-03-02	Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion.
MXPA04004450A (es)	2004-08-11	Nuevos compuestos y composiciones como inhibidores de catepsina s.
EP1436279B8 (en)	2008-10-29	Chemical compounds
MXPA04005176A (es)	2004-08-11	N-ureido-piperidinas como antagonistas viii para receptores ccr-3.
UA87829C2 (en)	2009-08-25	Fused pyrrolocarbazoles
AU2001274138A1 (en)	2001-12-17	Propanolaminotetralines, preparation thereof and compositions containing same
WO2005020911A3 (en)	2005-07-21	Benzo[1, 3]dioxole compounds, pharmaceutical compositions thereof, and processes of making and using the same
SG143979A1 (en)	2008-07-29	Novel compounds and compositions as cathepsin inhibitors

Legal Events

Date	Code	Title	Description
2008-04-25	FG	Grant or registration